Department of Otolaryngology-Head & Neck Surgery, New York University School of Medicine, New York, New York, U.S.A.
Department of Radiation Oncology, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, U.S.A.
Laryngoscope. 2021 Apr;131(4):E1147-E1155. doi: 10.1002/lary.29046. Epub 2020 Sep 1.
Race predicts overall mortality (OM) of laryngeal squamous cell carcinoma (LSCC) in the United States (US). We assessed whether racial disparities affect cancer-specific mortality (CSM) using the Surveillance, Epidemiology, and End Results (SEER) database.
Adults with LSCC from 2004 to 2015 were selected. Univariable and multivariable Cox proportional hazards and Fine-Gray competing-risks regression analysis adjusted for clinicodemographic factors defined hazard ratios (aHR).
We identified 14,506 patients. The median age was 63 years. Most were male (11,725, 80.8%) and white (11,653, 80.3%), followed by Black (2294, 15.8%). Most had early-stage disease (7544, 52.0%) and received radiotherapy only (4107, 28.3%), followed by chemoradiation (3748, 25.8%). With median follow-up of 60 months, overall 3- and 5-year OM were 34.0% and 43.2%; CSM were 16.0% and 18.9%, respectively. Black patients had higher OM than white patients on univariable (HR 1.35, 95% CI, 1.26-1.44, P < .001) and multivariable (aHR 1.10, 95% CI, 1.02-1.18, P = .011) analyses. Black patients had higher CSM on univariable analysis (HR 1.22, 95% CI, 1.09-1.35, P < .001) but not on multivariable CSM analysis (aHR 1.01, 95% CI, 0.90-1.13, P = .864). On multivariable analysis, year of diagnosis, age, disease site, stage, treatment, nodal metastasis, marital status, education, and geography significantly predicted CSM.
On multivariable analyses controlling for sociodemographic, clinical, and treatment characteristics, Black and white patients differed in OM but not in CSM. However, Black patients presented with greater proportions of higher stage cancers and sociodemographic factors such as income and marital status that were associated with worse outcomes. Efforts to target sociodemographic disparities may contribute to the mitigation of racial disparities in LSCC.
4 Laryngoscope, 131:E1147-E1155, 2021.
在美国,种族可预测喉鳞状细胞癌(LSCC)的总死亡率(OM)。我们使用监测、流行病学和最终结果(SEER)数据库评估种族差异是否会影响癌症特异性死亡率(CSM)。
从 2004 年至 2015 年选择 LSCC 成年患者。使用单变量和多变量 Cox 比例风险和 Fine-Gray 竞争风险回归分析调整了临床病理特征定义的风险比(aHR)。
我们确定了 14506 名患者。中位年龄为 63 岁。大多数是男性(11725 例,80.8%)和白人(11653 例,80.3%),其次是黑人(2294 例,15.8%)。大多数为早期疾病(7544 例,52.0%),仅接受放疗(4107 例,28.3%),其次是放化疗(3748 例,25.8%)。中位随访 60 个月,总 3 年和 5 年 OM 分别为 34.0%和 43.2%;CSM 分别为 16.0%和 18.9%。单变量分析(HR 1.35,95%CI,1.26-1.44,P <.001)和多变量分析(aHR 1.10,95%CI,1.02-1.18,P = 0.011)均显示黑人患者的 OM 高于白人患者。黑人患者在单变量分析中 CSM 更高(HR 1.22,95%CI,1.09-1.35,P <.001),但多变量 CSM 分析中 CSM 并无差异(aHR 1.01,95%CI,0.90-1.13,P = 0.864)。多变量分析显示,诊断年份、年龄、疾病部位、分期、治疗、淋巴结转移、婚姻状况、教育程度和地理位置显著预测 CSM。
在多变量分析中,控制社会人口统计学、临床和治疗特征后,黑人和白人患者在 OM 方面存在差异,但在 CSM 方面没有差异。然而,黑人患者表现出更高比例的晚期癌症和社会人口统计学因素,如收入和婚姻状况,这些因素与较差的预后相关。针对社会人口统计学差异的努力可能有助于减轻 LSCC 中的种族差异。
4《喉镜》,131:E1147-E1155,2021。